Yiannakouris N, Yannakoulia M, Melistas L, Chan J L, Klimis-Zacas D, Mantzoros C S
Department of Home Economics, Harokopio University, 17671 Athens, Greece.
J Clin Endocrinol Metab. 2001 Sep;86(9):4434-9. doi: 10.1210/jcem.86.9.7842.
Genetic variation at the leptin receptor gene locus may play an important role in the pathophysiology of human obesity, a leptin-resistant state. Previous studies exploring potential associations between leptin receptor gene polymorphisms and obesity have reported conflicting results. The aim of this study was to evaluate a genetically homogeneous population for associations between body composition variables and three common leptin receptor gene polymorphisms (K109R, Q223R, and K656N) that have potential functional significance as well as to assess the contributions of these polymorphisms to the variability of obesity. One hundred and eighteen consecutively enrolled subjects (62 women: mean age, 17.5 +/- 1.6 yr; body mass index range, 16.2-30.1; 56 men: mean age, 17.8 +/- 1.8 yr; body mass index range, 15.4-35.9) were genotyped for the three polymorphisms, and their body mass index, sum of 4 skinfolds, fat-free mass, percent fat mass, serum leptin levels, caloric intake, fat intake, and exercise patterns were determined. Allele frequencies were estimated by the gene-counting method, and genotype distributions between 89 normal weight (body mass index, < or =25 kg/m(2)) and 29 overweight-obese (body mass index, >25 kg/m(2)) subjects were compared using chi(2) test (using codominant, dominant, and recessive models). Analysis of covariance was also performed to evaluate associations between the polymorphisms and body composition variables after controlling for potential confounders. For the Q223R polymorphism, there was a higher prevalence of the R223 allele in the homozygous form among overweight-obese subjects vs. normal weight subjects (20.7% vs. 4.5%; P = 0.01). Furthermore, simple and multiple regression analyses revealed that the R223 allele in the homozygous form is a significant predictor of both body mass index (P = 0.015) and percent fat mass (P = 0.02) even after adjusting for age and gender and explains 4.5% of the variance in percent fat mass and 5% of the variance in body mass index. There was no significant difference in allele frequencies or genotype distributions for the K109R or K656N polymorphisms. These findings support the hypothesis that the Q223R polymorphism (but not the K109R or K656N polymorphism) of the leptin receptor gene is associated with obesity and predicts a small percentage of body weight and body composition variability in a genetically homogeneous population.
瘦素受体基因位点的遗传变异可能在人类肥胖(一种瘦素抵抗状态)的病理生理过程中发挥重要作用。先前探索瘦素受体基因多态性与肥胖之间潜在关联的研究报告了相互矛盾的结果。本研究的目的是评估一个基因同质人群中身体成分变量与三种具有潜在功能意义的常见瘦素受体基因多态性(K109R、Q223R和K656N)之间的关联,并评估这些多态性对肥胖变异性的贡献。对118名连续入组的受试者(62名女性:平均年龄,17.5±1.6岁;体重指数范围,16.2 - 30.1;56名男性:平均年龄,17.8±1.8岁;体重指数范围,15.4 - 35.9)进行了这三种多态性的基因分型,并测定了他们的体重指数、4处皮褶厚度之和、去脂体重、体脂百分比、血清瘦素水平、热量摄入、脂肪摄入和运动模式。通过基因计数法估计等位基因频率,并使用卡方检验(使用共显性、显性和隐性模型)比较了89名正常体重(体重指数,≤25 kg/m²)和29名超重 - 肥胖(体重指数,>25 kg/m²)受试者之间的基因型分布。在控制潜在混杂因素后,还进行了协方差分析以评估多态性与身体成分变量之间的关联。对于Q223R多态性,超重 - 肥胖受试者中纯合形式的R223等位基因患病率高于正常体重受试者(20.7%对4.5%;P = 0.01)。此外,简单和多元回归分析显示,即使在调整年龄和性别后,纯合形式的R223等位基因仍是体重指数(P = 0.015)和体脂百分比(P = 0.02)的显著预测因子,并且解释了体脂百分比变异的4.�%和体重指数变异的5%。K109R或K656N多态性的等位基因频率或基因型分布没有显著差异。这些发现支持了这样的假设,即瘦素受体基因的Q223R多态性(而非K109R或K656N多态性)与肥胖相关,并在一个基因同质人群中预测了一小部分体重和身体成分的变异性。